We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
Cap. Flow
+$64.5M
Cap. Flow %
0.35%
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$285M
2
UNH icon
UnitedHealth
UNH
+$53.5M
3
GE icon
GE Aerospace
GE
+$36.4M
4
PEP icon
PepsiCo
PEP
+$12.5M
5
RL icon
Ralph Lauren
RL
+$10.1M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$39.4M
2
PM icon
Philip Morris
PM
+$20.6M
3
AAPL icon
Apple
AAPL
+$18.7M
4
KO icon
Coca-Cola
KO
+$17.7M
5
MO icon
Altria Group
MO
+$13.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.84%
2 Energy 18.16%
3 Financials 14.69%
4 Healthcare 10.53%
5 Technology 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMI.WS
251
DELISTED
Kinder Morgan Inc
KMI.WS
$0 ﹤0.01%
25,010
– –
7 8 9 10
11

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
  • Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
  • Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
  • Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
  • Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.